Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00075777 · ClinicalTrials.gov registry record · NA
Valproic Acid in Treating Patients With Kaposi's Sarcoma
A NA study, sponsored by AIDS Malignancy Consortium.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT00075777 is a NA study that has completed, run by AIDS Malignancy Consortium. The registered enrollment target is 19 participants.
The verdict
NCT00075777, a NA study, has completed, sponsored by AIDS Malignancy Consortium.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
RATIONALE: Valproic acid may help stop the growth of Kaposi's sarcoma cells by blocking the enzymes necessary for tumor cell growth. PURPOSE: This clinical trial is studying valproic acid in treating patients with HIV-related Kaposi's sarcoma.
Interventions
- DRUG valproic acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2005-02 |
| Est. Completion | 2008-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00075777
The ClinicalTrials.gov registry entry for NCT00075777 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AIDS Malignancy Consortium, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which valproic acid is the first listed.
NCT00075777 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00075777 about?
NCT00075777 is a clinical study titled "Valproic Acid in Treating Patients With Kaposi's Sarcoma". RATIONALE: Valproic acid may help stop the growth of Kaposi's sarcoma cells by blocking the enzymes necessary for tumor cell growth. PURPOSE: This clinical trial is studying valproic acid in treating patients with HIV-related Kaposi's sarcoma.
What is the current status of trial NCT00075777?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2005-02. Estimated completion is 2008-02.
What interventions are being tested in trial NCT00075777?
The interventions under investigation include: valproic acid (DRUG).
Who is sponsoring clinical trial NCT00075777?
This trial is sponsored by AIDS Malignancy Consortium, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.